Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment

被引:74
作者
Aparicio, Thomas [1 ]
Navazesh, Atika [1 ]
Boutron, Isabelle [2 ]
Bouarioua, Nadia [1 ]
Chosidow, Denis [3 ]
Mion, Mathieu [4 ]
Choudat, Laurence [5 ]
Sobhani, Iradj [1 ]
Mentre, France [2 ]
Soule, Jean Claude [1 ]
机构
[1] Univ Paris 07, Hop Bichat, AP HP, Serv Hepatogastroenterol,UFR Med, Paris, France
[2] Univ Paris 07, Hop Bichat, AP HP, Dept Epidemiol Biostat & Rech Clin,UFR Med, Paris, France
[3] Univ Paris 07, Hop Bichat, AP HP, Serv Chirurg Digest,UFR Med, Paris, France
[4] Univ Paris 07, Hop Bichat, AP HP, Serv Geriatrie,UFR Med, Paris, France
[5] Univ Paris 07, Hop Bichat, AP HP, Serv Anatomopathol,UFR Med, Paris, France
关键词
Colon cancer; Rectal cancer; Elderly; Prognostic factor; DEFINED FRENCH POPULATION; III COLON-CANCER; ADJUVANT-CHEMOTHERAPY; POOLED ANALYSIS; RECTAL-CANCER; SURVIVAL; AGE; FLUOROURACIL; DIAGNOSIS; OLDER;
D O I
10.1016/j.critrevonc.2008.11.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Several database studies report a lack of care in elderly patients with colorectal cancer. Purpose: To describe the management of elderly patients admitted for colorectal cancer; to identify factors associated with standard management according to recommendations and to study factors influencing the survival. Patients and methods: All consecutive patients over 75 years managed for a colorectal adenocarcinoma in our hospital from 1995 to 2000 and followed until 2006 were retrospectively included. The appropriateness of the management of their disease according to the recommendations available at that time was assessed. Several risk factors in receiving the standard cancer treatment were tested using univariate and then multivariate logistic regression. Risk factors of survival were studied using univariate and then multivariate survival analysis. Results: One hundred and ten patients were included. Median age was 82 years (range: 75-96). A surgical treatment was performed in 96 patients. The median overall survival was 32 (1-108) months. A standard cancer treatment according to recommendations was performed in 53 (48%) patients: adjuvant chemotherapy in 6/23 patients with stage III tumour, palliative chemotherapy in 3/18 patients with stage IV tumour and adjuvant radiotherapy in 4/14 patients who had a rectal tumour resection. Multivariate analysis retains tumour stage I or II (OR = 7.6, 95% C.I. = [2.9-19.9], p < 0.0001) as the only factor associated with standard treatment and presence of metastasis (HR = 3.9, 95% C.I. [1.4-10.8], p = 0.005), and Charlson's score >3 (HR = 28.9, 95% C.I. [2.5-335.6], p = 0.001) as independent risk factors of poor survival. Conclusions: Fifty two percent of elderly patients have had a sub-standard cancer treatment. The majority had a surgical treatment, but only a few received chemotherapy or radiotherapy. Metastasis, older age and Charlson's comorbidity score are the main prognosis factors of poor survival. (c) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:249 / 257
页数:9
相关论文
共 35 条
[21]   Stage III colon cancers -: Why adjuvant chemotherapy is not offered to elderly patients [J].
Mahoney, T ;
Kuo, YH ;
Topilow, A ;
Davis, JM .
ARCHIVES OF SURGERY, 2000, 135 (02) :182-185
[22]   Effect of age, period of diagnosis and birth cohort on large bowel cancer incidence in a well-defined French population, 1976-1995 [J].
Mitry, E ;
Benhamiche, AM ;
Couillault, C ;
Roy, P ;
Faivre-Finn, C ;
Clinard, F ;
Faivre, J .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2002, 11 (06) :529-534
[23]   LEVAMISOLE AND FLUOROURACIL FOR ADJUVANT THERAPY OF RESECTED COLON-CARCINOMA [J].
MOERTEL, CG ;
FLEMING, TR ;
MACDONALD, JS ;
HALLER, DG ;
LAURIE, JA ;
GOODMAN, PJ ;
UNGERLEIDER, JS ;
EMERSON, WA ;
TORMEY, DC ;
GLICK, JH ;
VEEDER, MH ;
MAILLIARD, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (06) :352-358
[24]   Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: A population-based study [J].
Neugut, AI ;
Fleischauer, AT ;
Sundararajan, V ;
Mitra, N ;
Heitjan, DF ;
Jacobson, JS ;
Grann, VR .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) :2643-2650
[25]   Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older [J].
Popescu, RA ;
Norman, A ;
Ross, PJ ;
Parikh, B ;
Cunningham, D .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2412-2418
[26]   A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients [J].
Sargent, DJ ;
Goldberg, RM ;
Jacobson, SD ;
Macdonald, JS ;
Labianca, R ;
Haller, DG ;
Shepherd, LE ;
Seitz, JF ;
Francini, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) :1091-1097
[27]   Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer:: A Spanish cooperative group for the treatment of digestive tumors study [J].
Sastre, J ;
Marcuello, E ;
Masutti, B ;
Navarro, M ;
Gil, S ;
Antón, A ;
Abad, A ;
Aranda, E ;
Maurel, J ;
Valladares, M ;
Maestu, I ;
Carrato, A ;
Vicent, JM ;
Díaz-Rubio, E .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3545-3551
[28]   Age and adjuvant chemotherapy use after surgery for stage III colon cancer [J].
Schrag, D ;
Cramer, LD ;
Bach, PB ;
Begg, CB .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (11) :850-857
[29]   Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results-medicare [J].
Schrag, D ;
Gelfand, SE ;
Bach, PB ;
Guillem, J ;
Minsky, BD ;
Begg, CB .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (17) :3712-3718
[30]  
STEIN BN, 1995, CANCER-AM CANCER SOC, V75, P11, DOI 10.1002/1097-0142(19950101)75:1<11::AID-CNCR2820750104>3.0.CO